The electrical activity resulting from stimulation by motor neurons regulates gene expression in skeletal muscle fibres. A recent study has suggested a mechanism by which distinct patterns of electrical stimulus might be integrated to control the contractile properties of these fibres.
What happens when one decides, as people of a certain age do, that it is time to run a marathon? The masochism of a training regime is designed to tune that flabby muscle into the ultimate racing machine. The result? We don't reach the Olympics, but we do make it to the finishing line, even though the first 5 kilometre practice run nearly brought us to our last gasping breath. The reason why we succeed is, in part, the training effect of increased neural stimulation on skeletal muscle fibres, through changing gene expression in the fibres. But how do muscle fibres use this increased neural activity, experienced a few times a week, to change their properties sufficiently to permit a successful marathon attempt? Recent work from Chin et al. [1] has taken us another step, but by no means the final one, towards unravelling this mystery.
Muscle fibres are specialised for particular tasks. Our fastest fibres express a fast isoform of the muscle motor protein myosin which hydrolyses ATP rapidly and generates high levels of force. Such fibres fatigue rapidly because they use inefficient glycolytic metabolism to generate ATP quickly. In contrast, slow fibres express the slow isoform of myosin, which hydrolyses ATP more slowly. Efficient oxidative metabolism can generate ATP rapidly enough to fuel these fibres. The trick in marathon running is to maximise the oxidative generation of ATP and use that energy to keep up a steady pace. Consequently, slow oxidative fibres are abundant in Olympic marathon runners [2] . Conversely, fast fibres are more common in athletes excelling at short-term strength events like the high jump or javelin, for which efficiency is less important and acceleration is everything.
In adult animals, the gene expression in muscle fibres is regulated, at least in part, by the electrical activity that the fibres receive from their motor neurons. Slow fibres are stimulated at a continuous low frequency, whereas fast fibres experience bursts of high-frequency firing interspersed with periods of rest. Applying these firing patterns to fibres of either type can induce the expression of the appropriate genes -if given a continuous, low-frequency stimulus, fast fibres can be induced to express genes that are usually expressed in slow fibres, and vice versa. Understanding how these types of electrical stimulus are integrated over time and translated into a command to activate the expression of specific genes forms the subject of discussion.
In the study by Chin et al. [1] , the investigation began with studies of two mouse genes that are regulated by electrical activity. Myoglobin is highly expressed in oxidative fibres to facilitate diffusion of oxygen from the blood to the mitochondria. Troponin-I slow is a specialized subunit of the trimeric troponin complex which mediates the calcium-sensitive activation of muscle contraction by exposing the actin filament in muscle fibres to myosin. The regulatory regions that control the expression of the myoglobin and troponin-I slow genes have binding sites for transcription factors of the nuclear factor of activated T cells (NFAT) family, originally found to be involved in T-cell signalling but now known to be expressed in a number of other cell types. Chin et al. [1] introduced reporter gene constructs driven by these regulatory regions into a mouse muscle cell line and demonstrated that NFAT is capable of activating the expression of the reporter gene. NFAT had no effect on the expression of a reporter gene driven by a variety of control promoter or enhancer elements, however.
Why is it interesting for muscle gene expression that activation of a known transcription factor leads to increased expression of reporter genes driven by its cognate DNA-binding site? The answer lies in the known pathway of activation of NFAT. Nuclear entry by NFAT, and hence NFAT-mediated transcriptional activation, is regulated by NFAT phosphorylation (Figure 1 ). NFAT proteins are retained in the cytoplasm when phosphorylated, but rapidly enter the nucleus when the phosphate group is removed. Dephosphorylation can be effected by calcineurin, a calcium-sensitive serine/threonine phosphatase that is activated transiently in the presence of calcium-calmodulin. The calcineurin pathway is more sensitive than some other calciumdependent pathways to small rises in calcium levels, yet calcineurin inactivates rapidly after a transient peak of calcium [3, 4] . These properties suggest that calcineurin would be sensitive to the higher average calcium signal thought to prevail in chronically active slow fibres, yet unresponsive to the calcium transients in response to electrical activity in fast muscle fibres.
Chin et al. [1] used the drug cyclosporin A (CsA) to test this idea. CsA inhibits calcineurin and therefore is predicted to prevent slow-fibre-specific gene expression by blocking the effects of increased intracellular calcium. Around 20% of the slow fibres in the soleus muscle of rats treated with CsA were converted to fast fibres, as revealed by the induction of expression of a myosin isoform that had the enzymatic and immunological properties of fast myosin. But the analysis of the expression of the endogenous slow-fibre-specific genes that contain NFAT sites in their regulatory regions was not reported in the study. CsA has been shown previously to induce loss of oxidative capacity in muscle cells, however, suggesting that it can inhibit the function of slow muscle fibres and possibly change muscle fibre type [5] . Thus, the work raises the possibility that NFAT proteins may be important regulators of muscle-specific gene expression and is consistent with the expression of a variety of NFAT transcription factors in human muscle cells [6, 7] .
As the authors themselves point out, the work leaves a number of issues still to be resolved. Chief among them is whether a calcineurin-dependent pathway mediates the effect of electrical activity patterns on fibre-type-specific gene expression, and, if so, whether calcineurin regulates most of the genes that are specifically expressed in slow muscle fibres or only a limited subset. The answer will come from a more detailed analysis of the CsA-treated animals than has so far been reported. CsA is a potent immunosuppressant and, given that CsA has a dramatic effect on animal behaviour and muscle regeneration [5, 7] , it is far from clear that CsA acts directly within muscle fibres. Even minor changes in neural activity have been previously reported to alter muscle fibre types, so effects of CsA on the nervous system should not be discounted. From another angle, the apparent lack of effect of CsA on 80% of the slow fibres in the soleus muscle is particularly intriguing. Are these fibres receiving a pattern of electrical activity that the administered doses of CsA are unable to block? Or are the affected fibres fundamentally different from the majority? In either case, the small change observed is reminiscent of the small increases in soleus fast fibres seen in mice deficient in another transcription factor, MyoD [8] . Perhaps calcineurin has a sufficiently broad substrate specificity to affect several transcription factors, thereby co-ordinating expression of a variety of genes.
Another issue that must be addressed is whether the NFAT sites in the regulatory regions of slow-musclespecific genes are actually required for fibre-type-specific expression of the exogenous reporter genes or of the corresponding endogenous genes. A recent examination of the troponin-I slow gene has revealed that the NFAT site can be removed without preventing slow-fibre-specific expression in transgenic mice [9] . For other genes, it may also be necessary to address this issue in the intact animal, Dispatch R893
Figure 1
The NFAT pathway and the suggested role of electrical activity. (a,b) because cultured muscle cells are similar to nascent embryonic fibres in that they differentially express fibretype-specific genes in the absence of imposed electrical activity (see [10] for an example). Electrical stimulation of cultured cells has been shown to alter myotube gene expression [11] , however, so analysis of at least some genes may be possible in culture.
The big question athletes should be asking is: how much voluntary training does it take to alter muscle fibre type? Sadly, it seems humans can do little about their expression of the different myosin isoforms, as we simply don't have that much control over our motor neurons. But the good news is that running a marathon is achievable because, with training, we can induce a greater oxidative power in our fast fibres. Could drugs help? Despite the enthusiasm of certain athletes and body builders for a drug that could enhance fast muscle, it is unlikely that anyone will win an Olympic strength event by taking potent immunosuppressants like CsA. 
